Skip to main content

The Baltimore Sun: Baltimore Consortium Forms Global Task Force to Study Zika, Find Vaccine

February 16, 2016 | Andrea K. McDaniels - Baltimore Sun

Read the full story at: http://www.baltimoresun.com/health/bs-hs-zika-task-force-20160215-story.html

Contact

Andrea K. McDaniels - Baltimore Sun
andrea.walker@baltsun.com

Related stories

    Friday, March 29, 2019

    12th Annual Dr. Aaron I. Grollman Visiting Professorship in Basic Sciences Lectureship Features Dr. Eva Harris

    Eva Harris, PhD, never met a mosquito she didn’t like. A Professor of Infectious Diseases and Vaccinology and Director of the Center for Global Health at the University of California, Berkley, Dr. Harris was recently the guest speaker at the University of Maryland School of Medicine’s (UMSOM) Dr. Aaron I. Grollman Visiting Professorship in Basic Sciences Lectureship, where she shared her research on the control of Zika, dengue, and chikungunya—the most prevalent mosquito-borne diseases in humans. She is also the Co-Founder and President of the Sustainable Sciences Institute (SSI), an international non-profit dedicated to developing sustainable local research and public health systems in resource-poor settings.


    Thursday, February 01, 2018

    UMSOM’s Monica McArthur, MD, PhD. Discusses Zika Virus and Challenges in Developing a Vaccine

    Zika vaccine development: two years on from the outbreak


    Thursday, January 05, 2017

    For the First Time, Researchers Identify Key Proteins That May Make Zika So Deadly

    Until it burst onto the scene earlier this year, Zika was an obscure, little-known virus. As a result, scientists know little about how it works. Over the past year, they have learned that it can cause a range of dangerous health problems, including birth defects such as microcephaly and neurological problems such as Guillain-Barré syndrome. But they don’t know which Zika protein or proteins are causing harm, or exactly how these proteins cause damage.


    Thursday, August 04, 2016

    UM SOM is Center Stage in Testing National Institutes of Health Zika Vaccine

    UM SOM'S Center for Vaccine Development, tapped previously for Ebola vaccine, now steps up to help develop first Zika vaccine.